Hyperinfection by Strongyloides stercoralis in a Renal Transplant Patient with SARS-CoV-2 Viral Coinfection
Main Article Content
Abstract
A 74-year-old male with a history of kidney transplantation and recent corticosteroid pulse therapy was admitted with fever and abdominal pain, initially attributed to a urinary tract infection. He progressed with hemoptysis, dyspnea, and respiratory failure, and was diagnosed with Strongyloides stercoralis hyperinfection syndrome, confirmed by colonic biopsy and bronchoalveolar lavage, in co-infection with SARS-CoV-2. Treatment with ivermectin and albendazole was initiated, leading to clinical recovery and parasitic eradication. Notably, the patient had a negative stool parasitology prior to transplantation. Strongyloides stercoralis infection is prevalent in tropical and subtropical regions. Diagnosis is challenging due to the low sensitivity of stool tests and limited availability of molecular methods, which may delay treatment.
Downloads
Article Details
Section

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
References
Qu TT, Yang Q, Yu MH, et al. Fatal strongyloides stercoralis hyperinfection syndrome in a patient with chronic kidney disease: a case report and literature review. Medicine (Baltimore). 2016;95(19):e3638. DOI: https://doi.org/10.1097/MD.0000000000003638
El-Sameed YA, Beejay N, Al Maashari R. Diffuse alveolar haemorrhage and severe hypoxemia from Strongyloides stercoralis hyperinfection syndrome. Clin Respir J. 2015;9(4):489-492. DOI: https://doi.org/10.1111/crj.12169
Calderon CA, Rodríguez F; Martínez W, et al. Hemorragia alveolar por strongyloides stercoralis en trasplante combinado riñón-páncreas: reporte de caso. Rev Colomb Neumol. 2019;31(2):44. DOI: https://doi.org/10.30789/rcneumologia.v31.n2.2019.390
Kim JM, Sivasubramanian G. Strongyloides hyperinfection syndrome among COVID-19 patients treated with corticosteroids. Emerg Infect Dis. 2022;28(7):1531-1533. DOI: https://doi.org/10.3201/eid2807.220198
Barros N, Montes M. Infection and hiperinfection with Strongyloides stercoralis: clinical presentation, etiology of disease, and treatment options. Curr Trop Med Rep. 2014;1:223-228. DOI: https://doi.org/10.1007/s40475-014-0030-y
World Health Organization. WHO guideline for public health control of strongyloidiasis. Geneva: World Health Organization; 2024.
Pereira CVM, Mastandrea GRA, Medeiros ACCS, et al. COVID-19 and strongyloidiasis: what to expect from this coinfection? Clinics (Sao Paulo). 2021;76:e3528. DOI: https://doi.org/10.6061/clinics/2021/e3528